Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $7.68 USD
Change Today +0.54 / 7.56%
Volume 492.9K
LXRX On Other Exchanges
Symbol
Exchange
LXRX is not on other exchanges.
As of 8:10 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Pablo Lapuerta M.D.

Chief Medical Officer and Executive Vice President, Lexicon Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

51$1,005,200
As of Fiscal Year 2014

Background*

Dr. Pablo Lapuerta, M.D. has been the Chief Medical Officer and Executive Vice President of Lexicon Pharmaceuticals, Inc., since March 2011 and February 2015 respectively. Dr. Lapuerta served as Executive Vice President of Safety & Pharmacovigilance and Executive Vice President of Clinical Development at Lexicon Pharmaceuticals, Inc. from August, 2014 to February 2015 and since February 2013 respectively. Dr. Lapuerta has over 11 years of experience in the pharmaceutical ...

Read Full Background

Corporate Headquarters*

8800 Technology Forest Place
The Woodlands, Texas 77381

United States

Phone: 281-863-3000
Fax: 281-863-8088

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BA
Harvard College
MD
Harvard Medical School

Other Affiliations*

Annual Compensation*

Salary$375,000
Bonus$70,350
Total Annual Compensation$445,350

Stock Options*

Restricted Stock Awards$135,880
All Other Compensation$7,040
Exercisable Options463,259
Unexercisable Options540,741
Total Number of Options1,004,000

Total Compensation*

Total Annual Cash Compensation$452,390
Total Short Term Compensation$445,350
Other Long Term Compensation$142,920
Total Calculated Compensation$1,005,200
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LXRX:US $7.68 USD +0.54

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Omar S. Ishrak Chairman and Chief Executive Officer
Medtronic plc
$1.5M
Alex Gorsky Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee
Johnson & Johnson
$1.5M
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
$2.0M
Timothy M. Ring Chairman, Chief Executive Officer and Chairman of Executive Committee
CR Bard Inc.
$1.1M
Michael F. Mahoney Chief Executive Officer, President and Director
Boston Scientific Corporation
$921.3K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LEXICON PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.